Apraclonidine ophthalmic and Pasireotide Extended-Release Injection
Determining the interaction of Apraclonidine ophthalmic and Pasireotide Extended-Release Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apraclonidine ophthalmic
Brand name: Iopidine
Synonyms: Apraclonidine
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apraclonidine ophthalmic-Pasireotide Injection
- Apraclonidine ophthalmic-Pasireotide Subcutaneous
- Apraclonidine ophthalmic-Patanase
- Apraclonidine ophthalmic-Patiromer
- Apraclonidine ophthalmic-Patiromer Sorbitex Calcium
- Apraclonidine ophthalmic-Pavacot
- Pasireotide Extended-Release Injection-Apremilast
- Pasireotide Extended-Release Injection-Aprepitant
- Pasireotide Extended-Release Injection-Aprepitant Capsules
- Pasireotide Extended-Release Injection-Aprepitant Injection
- Pasireotide Extended-Release Injection-Aprepitant Intravenous
- Pasireotide Extended-Release Injection-Aprepitant Oral Suspension